期刊文献+

三结构域蛋白29在人胃癌组织的表达及其临床意义 被引量:1

Expression of tripartite motif - containing protein 29 in gastric cancer tissue and its clinical significance
原文传递
导出
摘要 目的探讨三结构域蛋白29(TRIM29)在胃癌组织中的表达及其临床意义。方法收集86例胃癌及癌旁组织,检测组织中TRIM29mRNA及蛋白的表达量,分析TRIM29表达水平与胃癌患者临床病理参数及预后的关系。结果胃癌组织与癌旁组织中TRIM29mRNA的相对表达量分别为1.490±0.059和1.010±0.079,两者比较差异有统计学意义(P〈0.01),且随着胃癌临床分期增高和肿瘤浸润程度加重而上调;TRIM29与有无淋巴结转移和患者预后情况差异有统计学意义(P〈0.05),而与性别、年龄和肿瘤分化程度无相关(P〉0.05)。结论胃癌组织中TRIM29表达显著上调,其高表达与肿瘤的肿瘤浸润程度、TNM分期和有无淋巴结转移有关。 Objective To investigate the expression of tripartite motif - containing protein 29 (TRIM29) in gastric cancer tissues, and its relationship with clinicopathological parameters. Methods We examined RNA and protein levels of TRIM29 expression in 86 paired stomach tumor and paratumor specimens by real -time fluorescent quantitative polymerase chain reaction (FQ -PCR) and Western blotting. The relationship of the TRIM29 expression with clinicopathological parameters and prognosis of gastric cancer patients was analyzed. Results The relative expression of TRIM29 was 1. 490± 0. 059 and 1. 010 ±0. 079 in gastric cancer tissues and normal adjacent tissues respectively, with significant difference (P 〈 0. 05). Higher mRNA and protein expression of TRIM29 in gastric cancer was associated with depth of invasion and TNM stage, while not with gender, age and differentiation degree (P 〉 0.05 ). Patients with lymphatic metastasis got higher Trim29 expression than in those with no lymphatic metastasis. Conclusion Expression levels of TRIM29 mRNA and protein in gastric cancer tissue are significantly up - regulated. TRIM29 expression is associated with invasion depth and TNM stages.
作者 许俊 刘志苏
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第2期307-309,共3页 Chinese Journal of Experimental Surgery
关键词 胃癌 三结构域蛋白29 淋巴结转移 Gastric cancer Tripartite motif-containing protein 29 Lymphatic metastasis
  • 相关文献

参考文献10

  • 1Kosaka Y, Inoue H, Ohmachi T, et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer [ J ]. Ann Surg Oncol, 2007,14 ( 9 ) : 2543-2549.
  • 2Jiang T, Tang H, Lu S, et al. Up-regulation of tripartite motif-contai- ning 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer [ J ]. Med Onco1,2013,30 (4) : 1-9.
  • 3Zhou ZY, Yang GY, Zhou J, et al. Significance of TRIM29 and 13-cate- nin expression in non-small-cell lung cancer [ J ]. J Chin Med Assoc, 2012,75 ( 6 ) : 269 -274.
  • 4Liu J, Welm B ,Boucher KM, et al. TRIM29 functions as a tumor sup- pressor in nontumorigenic breast ceils and invasive ER + breast canc- er[Jl. Am J Pathol,2012,180(2) :839-847.
  • 5Kanno Y,Watanabe M, Kimura T, et al. TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer [ J ]. Acta Histo- chem,2014,116(5) :708-712.
  • 6Xiang Y, Ma N, Wang D, et al. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 direct- ly:a novel epigenetic therapy independent of decitabine [ J ]. Onco- gene,201d ,33 (3) :375-386.
  • 7Li X,Zhang Y, Shi Y, et al. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer [ J ]. J Cell Mol Med, 2011,15 ( 9 ) : 1887 -1895.
  • 8Yuan Z, Villagra A, Peng L, et al. The ATDC ( TRIM29 ) protein binds p53 and antagonizes p53-mediated functions [ J ]. Mol Cell Biol, 2010,30(12) :3004-3015.
  • 9Wang L, Heidt DG, Lee C J, et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and β-catenin sta- bilization [ J ]. Cancer Ce11,2009,15 ( 3 ) :207-219.
  • 10Masuda Y, Takahashi H, Hatakeyama S. TRIM29 regulates the p63- mediated pathway in cervical cancer ceils[ J]. Biochim Biophys Acta, 2015,1853( 10 Pt A) :2296-2305.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部